We have constructed a novel DNA expression vector
There are many expression vectors which can be used in eukaryotic cells. However, transfection of conventional plasmid vectors usually results in only a single or a few recombinant DNA molecules reaching the nucleus. Consequently, only a limited number of transcripts can be generated. To increase expression levels, several selfamplifying systems of gene transfer have been developed. Some of these self-amplifying systems use RNA genomes of alphaviruses, such as Sindbis virus [1] [2] [3] and Semliki Forest virus (SFV). 4, 5 SFV, a member of the Alphavirus genus, is a smallenveloped virus with a single-stranded RNA genome of positive polarity. The 5′ two-thirds of the viral genome encode nonstructural (replication) proteins (nsPs1-4) and the 3′ one-third encodes structural proteins. 6, 7 Upon infection, the RNA genome functions as mRNA for the translation of nonstructural proteins. These subsequently replicate the virus by copying the plus-strand RNA genome into minus-strand RNA and vice versa. The minusstrand RNA also serves as a template for the synthesis of a shorter subgenomic RNA which encodes the structural proteins. Transcription starting at the internal subgenomic promoter in the minus-strand results in the production of large amounts of subgenomic mRNA. 6, 7 SFV-derived vectors are based on the insertion of a genomic SFV cDNA into an SP6 promoter plasmid, and subsequent modification by deletion of the SFV structural genes to allow for the insertion of heterologous DNA as part of the SFV replicon. 4 Since the in vitro transcript from such constructs also encodes the SFV replicase, high levels of expression of the heterologous gene can be achieved by directly transfecting the recombinant RNA into cells. It was reported that recombinant RNA vectors based on SFV were transfected with high efficiency into animal tissue culture cells by means of electroporation. 4 Although this system can be used, the preparation of capped RNA vectors by in vitro transcription is necessary before transfection and the RNA molecules are unstable in general. Therefore, it is of great use to construct a DNA vector based on self-amplifying systems of SFV, especially in consideration of in vivo expression. In this report, we describe the development of an SFVderived DNA-based expression vector which can initiate the replication cascade in transfected mammalian cells to produce high-level expression of a reporter gene. Furthermore, we demonstrate that the transfection of cells with this SFV-based DNA vector results in cell death, along with the release of large amounts of heterologous proteins encoded in the vector.
Plasmid pSFV3 (GIBCO BRL, Grand Island, NY, USA), an SFV-based plasmid vector, contains nsPs genes followed by a subgenomic RNA promoter and a polylinker cassette which replaces the structural genes of SFV (Figure 1a) . 4 The nsPs genes of pSFV are under the transcriptional control of the SP6 promoter; therefore, in vitro transcription and capping of the 5′ end are required for the expression of the gene of interest in mammalian cells. To place pSFV3 under the control of a RNA polymerase II promoter, a cytomegalovirus (CMV) immediate-early (IE) enhancer/promoter sequence was inserted upstream of the nsP1 gene. In addition, to ensure that mRNA transcribed from the plasmid was properly terminated, a simian virus (SV) 40 late polyadenylation signal sequence was inserted downstream of the polylinker cassette (pSFV3-CMV-pA). The CMV-IE enhancer/promoter sequence and the SV40 polyadenylation signal sequence were obtained by polymerase chain reaction using the pCI Mammalian Expression Vector (Promega, Madison, WI, USA) as a template. Plasmid pSFV3-CMV-lacZ-pA was constructed by the insertion of the E. coli ␤-galactosidase gene (lacZ) into the polylinker cassette of pSFV3-CMV-pA (Figure 1b) . Plasmid pSFV3A5976-lacZ was constructed by the deletion of the nsPs genes from pSFV3-CMV-lacZ-pA (Figure 1c ).
To compare the expression level of lacZ from pSFV3-CMV-lacZ-pA and pSFV3A5976-lacZ, baby hamster kidney (BHK) cells were transfected with these plasmid vectors as follows. BHK cells were plated into a 24-well plate at a density of 1 × 10 5 cells per well in 0.5 ml of Iscove's modified Dulbecco's medium (IMDM; GIBCO BRL) with 10% (v/v) fetal calf serum (FCS) and incubated at 37°C in a 5% CO 2 humidified atmosphere. Eighteen hours later, transfection of pSFV3-CMV-lacZ-pA or pSFV3A5976-lacZ was performed. Starburst polyamidoamine dendrimers (generation 4; Yunitika, Osaka, Japan) 8 were used as mediators of DNA transduction. Plasmid DNA was prepared by diluting either 3.0 g of pSFV3-CMV-lacZ-pA or 1.8 g of pSFV3A976-lacZ (equivalent number of plasmid molecules) in 270 l of plain IMDM per well. Twenty micrograms of dendrimers were diluted in 130 l of IMDM and added drop by drop to the DNA solution. The solution was then gently mixed and incubated at room temperature for 15 min. The medium in each well was removed, cells were rinsed twice with IMDM, and 400 l of the DNA-dendrimer mixture were added to each well. After 3 h of incubation at 37°C in a 5% CO 2 humidified atmosphere, the DNA-dendrimer mixture was replaced by 1 ml of IMDM with 10% FCS. After 24 and 48 h of culture, a quantitative ␤-galactosidase assay was performed. The expression level of ␤-galactosidase obtained following transduction of pSFV3-CMV-lacZ-pA was more than 20-fold higher than that obtained with the pSFV3A5976-lacZ (Figure 2 CMV-lacZ-pA showed a dense blue color, while only a limited number of cells incubated with pSFV3A5976-lacZ demonstrated a very faint color (Figure 3) . However, after overnight staining there was no difference in the frequency of positively stained cells, and it was estimated that 25-35% of the cells were positively stained in both pSFV3-CMV-lacZ-pA-and pSFV3A5976-lacZ-transfected cells. Unexpectedly, differences in appearance were observed between the cells transfected with pSFV3-CMVlacZ-pA and pSFV3A5976-lacZ. Most of the cells transfected with pSFV3A5976-lacZ maintained the same shape as untransfected cells, while the cells transfected with pSFV3-CMV-lacZ-pA showed a condensed round form. Figure 4 shows the time-course of ␤-galactosidase activity in cell lysates and culture medium of pSFV3-CMV-lacZ-pA-transfected cells. Transfection was performed as described above except that the initial number of BHK cells was 2 × 10 4 per well. ␤-Galactosidase activity in the lysates of the cells transfected with pSFV3-CMVlacZ-pA showed a transient increase with a peak 36 h after transfection. In contrast, ␤-galactosidase activity in the medium began to increase 36 h after transfection and showed a delayed peak at 72 h. In the medium of pSFV3A5976-lacZ-transfected cells, measurable activity of ␤-galactosidase was not detected (data not shown). ␤-Galactosidase is an intracellular protein and is not released from cells. The leakage of ␤-galactosidase from pSFV3-CMV-lacZ-pA-transfected cells suggests that the overproduction of ␤-galactosidase resulted in cell death and release of the protein into the medium. Another comparative study of transfection using pSFV3-CMV-lacZ-pA and pSFV3A5976-lacZ was done in human 293 cell line. Although X-gal staining of transfected cell cultures and ␤-galactosidase assay in cell lysates revealed lower expression levels in 293 cells than in BHK cells, the level of expression with pSFV3-CMV-lacZ-pA was higher than with pSFV3A5976-lacZ (data not shown). This is the first article demonstrating a high level of expression of an exogenous gene by a plasmid vector constructed using a SFV replication system. Recently, Herweijer et al 9 and Dubensky et al 10 independently reported that they constructed plasmid vectors from Sindbis virus, a subgroup III Alphavirus with two envelope proteins, as compared with SFV which has three envelope proteins. In their systems as well, they showed 10-to 30-fold higher expression compared with conventional methods.
Comparison of ␤-galactosidase reporter gene expression between pSFV3-CMV-lacZ-pA and pSFV3A5976-lacZ plasmids showed that the nsPs genes were essential for highlevel expression of ␤-galactosidase. After transfection of pSFV3-CMV-lacZ-pA, an initial plus-strand full-length RNA is transcribed in the nucleus, translocated into the cytoplasm, and then translated into the nsPs of SFV. This initiates the replication cascade, and consequently, the highlevel expression of ␤-galactosidase is achieved. However, protein synthesis in the transfected cell is probably inhibited due to competition for translational machinery with self-amplified RNA derived from the plasmid. Protein synthesis in host cells infected by wild-type SFV is inhibited by the competitive production of viral proteins, 7 consequently leading to cell death.
A major advantage of the SFV-derived plasmid vector, pSFV3-CMV-pA, is a high-level expression of an exogenous gene using the self-amplifying systems of SFV. In addition, this vector is transfected into cells as doublestranded DNA. Therefore, there is no need for in vitro transcription and mRNA capping as required for the transfection of previously described SFV-derived RNA vectors.
